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Vena caval thrombosis has posed a surgical therapeutic challenge for many years. Histor- 
ically, spiral vein grafts and synthetic materials used as prostheses have had 'variable 
results. The use of the stent may serve as a more promising alternative when used in the 
capacity to relieve caval obstruction. A case is reported in which a young woman with 
Klippel-Tr~naunay s ndrome has exercise intolerance and associated hypotensive cardio- 
vascular collapse caused by inferior vena caval thrombosis. Recanalization of her inferior 
vena cava was successfully achieved and subsequently maintained through the placement 
of two Wallstents across the lesion. Although most venous tenting procedures have thus 
far been used in the treatment of venous obstruction caused by malignancy, inferior vena 
cava stenting in this patient with inferior vena caval thrombosis and Klippel-Tr+natmay 
syndrome suggests that venous tenting might offer an alternative therapeutic modality in 
treating a broader spectrum of occlusive venous disease. (J Vasc Surg 1997;26:155-9.) 
Historically, thrombosis of the vena cava has 
posed a surgical therapeutic challenge. Early compar- 
ative studies that assessed patency rates for prosthetic 
and autologous grafts were disappointing? Replace- 
ment of the vena cava with grafts is particularly hin- 
dered by its large diameter, low pressure, and low 
flow? ,3 More recently, synthetic materials and pros- 
thetic stents have provided the surgeon with alterna- 
tive interventional management options. The stent, 
in particular, is a potentially promising device, in 
view of the poor results of previous materials. 
In 1900, Klippel and Tr~naunay 4 first described 
the pathologic condition that currently bears their 
names in the "Du Naevus Variqueux Osteohypertro- 
phique." They described a syndrome characterized 
by a nevus on the affected extremity, varicose veins of 
the same limb, and hypertrophy of both soft and 
bony tissues of the affected extremity. Servelle, 5 in a 
review of 768 operations in patients with Klippel- 
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Tr~naunay syndrome, documented that the over- 
whelming majority of venous abnormalities occur in 
the lower extremity. Furthermore, limb elongation is 
invariably present, whereas the frequency of other 
associated symptoms and structural abnormalities 
can vary. 5 Anomalies of the deep veins of the in- 
volved extremity, including hypoplasia, atresia, apla- 
sia, and valvular agenesis, can be dreaded compo- 
nents of  this rare syndrome. 6 Often, large superficial 
varicosities develop as collateral conduits for the ob- 
structed eep venous systcm. 5 Nevertheless, venous 
insufficiency may still ensue, resulting in stasis, severe 
edema, and other associated complications. The 
therapeutic dilemma of managing vcna caval throm- 
bosis combined with the rare and complicating con- 
dition of  Klippel-Tr4naunay s ndrome posed a diffi- 
cult and interesting clinical problem in a patient 
recently treated at our medical center. 
CASE REPORT 
The patient was a 27-year-oM woman with a medical 
history significant for Klippel-Tr~naunay s ndrome, nota- 
ble for a long history of venous abnormalities of the left 
lower extremity. She had a deep venous thrombosis of the 
left lower extremity, with a subsequent pulmonary embo- 
lus prompting the placement of a caval filter in October 
1988. 
She recently came to our medical center with symp- 
toms of increased leg swelling with exercise and associated 
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Fig. 1. Iliac venogram with thrombosis of the inferior 
vena cava. Note the anomalous left iliac venous system 
(arrow). 
hypotensive cardiovascular collapse, relieved by leg eleva- 
tion. The patient had many of the associated stigmata of 
Klippel-Tr4naunay s ndrome, including unilateral lower 
extremity hypertrophy, edema, and port-wine stains. A 
duplex ultrasound examination was performed and was 
difficult to interpret because of the patient's underlying 
venous anomalies. A physiologic workup involving upright 
cycle ergometry was performed that revealed that the pa- 
tient had poor exercise tolerance, stopping after 4 minutes, 
with diminished cardiac preload caused by decreased ve- 
nous return. A venogram revealed large anomalous venous 
drainage channels of the left lower extremity, consistent 
with Klippel-Tr~naunay syndrome (Fig. 1). It further e- 
vealed thrombosis of the inferior vena cava at the level of 
the Greenfield filter as a cause of her diminished cardiac 
preload (Fig. 2; note the low placement of the Greenfield 
filter). An aortogram was also performed that effectively 
ruled out any arterial component toher vascular anomalies. 
She then underwent a revascularization procedure of 
the vena cava to improve her venous return. To facilitate 
recanalization f the vena cava, the filter was removed by 
direct open surgical approach. A cavotomy was performed 
and the filter was excised. The organized thrombus was 
resected and the vena cava was repaired primarily. Under 
direct vision, the remainder of the vena cava was recana- 
lized by balloon angioplasty. A Wallstent was subsequently 
placed in the area of the caval angioplasty under direct 
vision. 
Before the operation, the patient had a lower extremity 
Fig. 2. Reconstituted inferior vana cava. Note the Green- 
field filter at the inferior portion (arrow). 
venous pressure of 27 cm of water, whereas the suprahe- 
patic caval pressure measured 10 cm of water, thereby 
yielding a I7 cm of water pressure gradient. After deploy- 
ment of the stent, there was equalization of venous pres- 
sures in the operating room. The patient was fully anfico- 
agulated with heparin after surgery. The patient tolerated 
the procedure well, but a retroperitoneal hematoma nd 
recurrent caval thrombosis ubsequently developed, pre- 
sumably because of the increased retroperitoneal pressure 
from the hematoma, the transient hypovolemic hypoten- 
sion, or the technical misadventure with the stent (Fig. 3). 
The heparin was discontinued and the patient was returned 
to the operating room for evacuation of the hematoma. 
She tolerated this procedure and began treatment with 
heparin and warfarin on postoperative day 2. She was then 
discharged home from the hospital and continued treat- 
ment with warfarin, with plans for recanalization of the 
inferior vena cava in 3 weeks. After readmission, a percuta- 
neous venogram was performed through a right femoral 
approach, demonstrating thrombosis of the stent. Balloon 
angioplasty was performed to recanalize the stent and the 
inferior vena cava. There was residual stenosis cephalad to 
the primary stent, and a second Wallstent was placed, 
overlapping the first. A final venogram was obtained that 
showed apatent venous ystem (Figs. 4 and 5). At the same 
time, a pulmonary angiogram showed no evidence of large 
pulmonary emboli. Lyric therapy was avoided because of 
the patient's hemorrhagic complications after the first re- 
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Fig. 3. Rethrombosed inferior vena cava with stent in 
place (arrow). 
Fig. 4. Inferior vena cavagram after recanalization. 
Fig. 5. Final stent positions after recanalization. 
canalization surgery. The patient was given heparin in the 
hospital. She was finally discharged home and resumed 
treatment with warfarin, with complete resolution of her 
symptoms. Three months after the procedure, she was able 
to walk for 20 minutes at 3 miles per hour on a treadmill, 
demonstrating functional venous return. Eight months 
after the procedure, a computed tomographic scan with 
contrast demonstrated a patent venous ystem (Fig. 6). 
DISCUSSION 
Of  particular interest in this case is the cause of  
the patient's exercise-induced hypotensive cardiovas- 
cular collapse. There are two plausible hypotheses. 
The first is the increased venous capacitance o f  the 
lower extremity caused by the Klippel-Tr~naunay 
syndrome. The alternative is the decreased cardiac 
venous return caused by vena caval thrombosis. 
Whether the caval thrombosis was de novo or re- 
suited from the trapping of  an embolus is uncertain. 
Still another possibility represents a contribution of  
both. It is still unclear how much each disease entity 
participated in the patient's exercise intolerance and 
secondary hypotensive cardiovascular collapse. 
Gloviczki et al., 6 in a report o f  40 patients with 
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Fig. 6. Computed tomographic s an with contrast shows Wallstent in patent inferior vena 
cava (arrow). 
Klippel-Trfinaunay syndrome, documented that the 
affected extremity was circumferentially larger in 75% 
of patients. Furthermore, the authors cited in their 
series that the greatest difference between extremities 
was 15 cm, indicating the potential significance of 
stasis and venous pooling in affected individuals. 
Venography, though performed in only four patients 
in Gloviczld's eries, revealed significant anomalies of 
the venous systems in all of the diseased extremities. 
These included deep venous insufficiency with in- 
competent perforators, extrinsic ompression of the 
veins, and large dilated deep tibial veins without 
valves. 6 All such anomalies can cause pooling of the 
blood supply in the affected extremity and thereby 
contribute to diminished venous return to the right 
side of the heart and the resultant exercise intoler- 
ance. 
Thrombosis of the vena cava, as experienced by 
the patient in this report, would clearly contribute to 
decreased cardiac preload. The initial pressure gradi- 
ent of 17 cm of water across the caval obstruction is
verification of this presumption. On recanalization, 
the pressure gradient was restored to normal and the 
patient's ymptoms were relieved. Furthermore, on 
rethrombosis of the inferior vena cava, the patient 
again had symptoms. Subsequent to the recanaliza- 
tion of the stented inferior vena cava, she was again 
relieved of her recurrent symptoms. 
Treatment ofvcna caval obstruction with stents is 
a new and innovative technique. Thus far, stenting 
has mainly been used as a technique to relieve caval 
obstruction caused by malignancy. 7-1° However, the 
implications for stenting may encompass a broader 
spectrum of disease and may promise to be an effec- 
tive therapeutic alternative to prosthetic or autolo- 
gous grafts. 
Initially, autologous spiral vein grafts were 
thought o be the optimal method of treatment for 
obstructed large veins, n Dory and Baker ~2 and 
Doty ~3 further popularized spiral vein grafts for 
treating the occluded vena cava. The procedure is 
tedious, with variable patency rates for spiral vein 
grafts depending on the location of  venous recon- 
struction. Furthermore, many patients do not have 
available autogenous vein for graft ing) 4,1s There- 
fore synthetic materials have been used, with the 
hope of  providing an alternative method for ve- 
nous repair. Expanded polytetrafluoroethylene 
(ePTFE) and Dacron are among such materials. 
ePTFE has had the most promising results, both 
experimentally and clinically. 14-~6 It has been re- 
ported that a thick pseudointima can develop in 
the ePTFE graft, thereby reducing the lumenal 
diameter of  the vessel to 60% of  its original size. 2 
Long-term patency has also been a problem. In 
view of  such complicating factors, stenting may 
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offer a promis ing alternative in the t reatment  of  
venous occlusion. 
The first inferior vena cava self-expanding me- 
tallic stent was inserted in 1986. I7 The focus of  
controversy sur round ing  the use of  the Wal lstent 
has centered on the diameter of the device. There 
has been speculat ion that the use of  a device with a 
diameter less than 20 mm cannot  be safely inserted 
into the inferior vena cava for fear of  poor  wall 
attatchment.  18 Entwisle et al. 7 recently described 
three patients who received Wallstents in their 
inferior venae cavae, all for mal ignancy associated 
obstruct ion.  The authors did not  report any prob-  
lems with stent migrat ion,  and each of the three 
patients tolerated the procedure well. 7 The use of  
stents in the t reatment  of  nonmal ignant  causes for 
inferior vena cava obstruct ion has not  been re- 
ported thus far in the l iterature. The pat ient in this 
report underwent  dep loyment  of a Wal lstent to 
relieve her inferior vena caval obstruct ion and has 
had a good result with relief of  her symptoms. 
Three months  after recanal izat ion of  her inferior 
vena cava, the stents remain patent  by clinical 
examinat ion,  with no evidence of  migrat ion by 
plain abdominal  radiograph. 
This report describes an unusual patient with 
vena caval thrombosis and Kl ippel-Trtnaunay s n- 
drome in whom exercise hypotension developed, 
presumably because of severe disruption of venous 
return. In correcting her caval obstruction with the 
use of a Wallstent, an innovative therapeutic tech- 
nique was used to treat a difficult vascular condit ion 
complicated by a rare disorder. Thus far, it seems to 
have offered promising results. 
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